Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
Thrombosis and Haemostasis|March 4, 1999
Fibrinolytic activity in peripheral atherosclerosis in the elderlyJ G van der Bom, M L Bots, F Haverkate, et al.
The New England Journal of Medicine|January 8, 1998
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarctionL Iacoviello, A Di Castelnuovo, P De Knijff, et al.
Thrombosis and Haemostasis|November 19, 1997
Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patientsM Kockx, M P de Maat, H C Knipscheer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Thrombosis Research|February 1, 1984
Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozololC Kluft, R M Bertina, F E Preston, et al.
Thrombosis and Haemostasis|April 30, 1984
Stanozolol-induced changes in fibrinolysis and coagulation in healthy adultsC Kluft, F E Preston, R G Malia, et al.
Human Reproduction (Oxford, England)|February 16, 2006
Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosisMoniek P M de Maat, E-M Bladbjerg, C Kluft, et al.
European Heart Journal|May 25, 1999
Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell functionP W Verheggen, M P de Maat, V M Cats, et al.
The Biochemical Journal|April 15, 1986
Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probeA J van Zonneveld, G T Chang, J van den Berg, et al.
The Journal of Nutrition|June 13, 1998
Dietary effects on coagulation factor VII vary across genotypes of the R/Q353 polymorphism in elderly peopleL I Mennen, M P de Maat, E G Schouten, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
Thrombosis and Haemostasis|March 4, 1999
Fibrinolytic activity in peripheral atherosclerosis in the elderlyJ G van der Bom, M L Bots, F Haverkate, et al.
The New England Journal of Medicine|January 8, 1998
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarctionL Iacoviello, A Di Castelnuovo, P De Knijff, et al.
Thrombosis and Haemostasis|November 19, 1997
Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patientsM Kockx, M P de Maat, H C Knipscheer, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Thrombosis Research|February 1, 1984
Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozololC Kluft, R M Bertina, F E Preston, et al.
Thrombosis and Haemostasis|April 30, 1984
Stanozolol-induced changes in fibrinolysis and coagulation in healthy adultsC Kluft, F E Preston, R G Malia, et al.
Human Reproduction (Oxford, England)|February 16, 2006
Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosisMoniek P M de Maat, E-M Bladbjerg, C Kluft, et al.
European Heart Journal|May 25, 1999
Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell functionP W Verheggen, M P de Maat, V M Cats, et al.
The Biochemical Journal|April 15, 1986
Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probeA J van Zonneveld, G T Chang, J van den Berg, et al.
The Journal of Nutrition|June 13, 1998
Dietary effects on coagulation factor VII vary across genotypes of the R/Q353 polymorphism in elderly peopleL I Mennen, M P de Maat, E G Schouten, et al.
Pageof 23